 |
Market Research Report
Vaccines Market Size By Age Group, By Disease, By Technology, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026 |
||||||
| Published by | Global Market Insights Inc. | Product code | 963771 | ||||
| Published | Content info | 192 Pages Delivery time: 2-3 business days |
|||||
| Price |
|
||||||
| Vaccines Market Size By Age Group, By Disease, By Technology, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026 | ||
| Published: October 8, 2020 | Content info: 192 Pages |
|
Title:
Vaccines Market Size By Age Group (Pediatric, Adult), By Disease (Cancer, Hepatitis, Pneumococcal Disease, DTP, Dengue, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus), By Technology (Conjugate, Live, Inactivated, Recombinant, Toxoid), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026 .
The vaccines market is likely to register significant gains in coming years owing to the growing geriatric population, high risk of fatality among the pediatric population, the ongoing fight against the COVID-19 pandemic, development of new vaccines for meningococcal diseases, and various government-sponsored initiatives towards the consolidation of their respective healthcare infrastructure.
Vaccine is a type of medicine which essentially trains the body's immune system to effectively fight a disease which it has not encountered before. It is known as a biological substance specifically designed for protecting humans from infections mainly caused by viruses and bacteria. Generally, vaccines are given in the form of injection, but at times some of them are given nasally or even orally.
The vaccines market is bifurcated in terms of age group, disease, technology, and regional landscape.
Based on age group, the vaccines market is categorized into adult and pediatric. Among these, adult segment will witness more than 16.7% CAGR through the projected time period. Factors such as high risk of mortality due to underlying comorbidities and age, increasing geriatric population, and high risk of acquiring COVID-19 infection will further drive the overall segment growth.
As in children, vaccines are equally important for adults to protect them from various diseases that might have a serious or deadly consequences if left untreated. A common instance is the Flu shots that are recommended for elderly population during flu season. It is extremely essential for those who are suffering from chronic illnesses and those above the age of 65.
With respect to disease, the vaccines market is classified into rotavirus, polio, meningococcal disease, human papilloma virus, influenza, dengue, DTP, pneumococcal disease, hepatitis, cancer, and others. Among these, meningococcal disease segment will witness substantial growth over the coming years. Factors such as development of new vaccines for meningococcal diseases, high risk of fatality in pediatric population, and regulatory approvals will drive the segmental growth.
In terms of technology, the overall vaccines market is segmented into toxoid, recombinant, inactivated, live, conjugate, and others. Among these, inactivated technology segment is likely to grow at a CAGR of more than 22% over the forecast timeframe. Increasing focus of research institutes and pharmaceutical companies towards the development of an effective COVID-19 vaccine based on inactivated virus technology will contribute towards industry growth.
Inactivated vaccines are a form of vaccine, in which the virus is inactivated during the vaccine making process. Various inactivated vaccines are available as whole-cell inactivated vaccines and utilized to protect against diseases like rabies, hepatitis A, polio, and flu.
From a regional frame of reference, Asia-Pacific vaccines market is likely to witness tremendous gains owing to presence of large geriatric population, increasing government initiatives for the development of numerous vaccination programs, and rising awareness.
Coronavirus Disease 2019 (COVID-19) Vaccines - Contract Development and Manufacturing Landscape
Vaccine Market By Technology, Indication, and End Use : Global Opportunity Analysis and Industry Forecast, 2020-2027
United States Vaccine Market By Type (Influenza, Retrovirus, Hepatitis, Polio, DTap, HIB, Pneumococcal Conjugate, Varicella, MMR and HPV), Products and Pipeline, Companies
Vaccines Global Market Report 2020-30: Covid 19 Impact and Recovery
Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology ; Disease Indication ; Route of Administration ; Patient Type and Geography
Vaccines Sales Market Report 2020-2030: Forecasts by Disease Type, Viral Diseases, Bacterial Diseases, Type of Vaccines, Distribution Channel, Age Group, Region, Competitive Landscape, COVID-19 Impact Analysis, Profiles of Leading Companies
Global Markets for Vaccine Technologies
Respiratory Virus Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030
Global Human Combination Vaccines Market 2020-2024
U.S. Vaccine Market, By Product Type (Human Vaccine, Animal Vaccine ), By End User - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
